Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 1787294-07-8 Chemical Structure| 1787294-07-8

Structure of Remibrutinib
CAS No.: 1787294-07-8

Chemical Structure| 1787294-07-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Remibrutinib is an effective and highly selective inhibitor of Bruton tyrosine kinase (Btk).

Synonyms: LOU064

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Remibrutinib

CAS No. :1787294-07-8
Formula : C27H27F2N5O3
M.W : 507.53
SMILES Code : O=C(NC1=CC(F)=CC(C2=NC=NC(N)=C2OCCN(C)C(C=C)=O)=C1C)C3=CC=C(C4CC4)C=C3F
Synonyms :
LOU064
MDL No. :MFCD32215329
InChI Key :CUABMPOJOBCXJI-UHFFFAOYSA-N
Pubchem ID :118107483

Safety of Remibrutinib

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H317-H334
Precautionary Statements:P304+P341-P342+P311-P302+P352-P333+P313-P321-P261-P272-P280-P261-P285-P363-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Remibrutinib

RTK

Isoform Comparison

Biological Activity

Description
Remibrutinib is a highly effective and orally bioavailable Bruton's tyrosine kinase (BTK) inhibitor, demonstrating an IC50 of 1 nM. It effectively suppresses BTK activity, with an IC50 of 0.023 µM in blood[1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05048342 Chronic Spontaneous Urticaria PHASE3 COMPLETED 2023-12-09 Novartis Investigative Site, N... More >>agoya, Aichi, 454-0012, Japan|Novartis Investigative Site, Urayasu, Chiba, 279-0011, Japan|Novartis Investigative Site, Izumiotsu, Osaka, 595-0025, Japan|Novartis Investigative Site, Neyagawa, Osaka, 572-0838, Japan|Novartis Investigative Site, Sakai, Osaka, 593-8324, Japan|Novartis Investigative Site, Takatsuki, Osaka, 569-0824, Japan|Novartis Investigative Site, Izumo-city, Shimane, 693 8501, Japan|Novartis Investigative Site, Itabashi-ku, Tokyo, 173-8610, Japan|Novartis Investigative Site, Minato, Tokyo, 108-0014, Japan|Novartis Investigative Site, Ota-ku, Tokyo, 143-0023, Japan|Novartis Investigative Site, Fukuoka, 811-1302, Japan|Novartis Investigative Site, Osaka, 554 0014, Japan|Novartis Investigative Site, Osaka, 558-0003, Japan Less <<
NCT05795153 Chronic Spontaneous Urticaria PHASE3 COMPLETED 2024-04-25 Little Rock Allergy and Asthma... More >> Clnc, Little Rock, Arkansas, 72205, United States|Florida Ctr Allergy Asthma Research ., Aventura, Florida, 33180, United States|Florida Ctr Allergy Asthma Research Suite 408, Aventura, Florida, 33180, United States|Finlay Medical Research, Greenacres City, Florida, 33467, United States|Treasure Valley Medical Research, Boise, Idaho, 83706, United States|Northshore University Health System ., Glenview, Illinois, 60077, United States|Allergy and Asthma Specialist P S C Main Center, Owensboro, Kentucky, 42301, United States|Allergy Asthma and Clinical Research, Oklahoma City, Oklahoma, 73120, United States|Allergy and Clinical Immunology Ass, Pittsburgh, Pennsylvania, 15241, United States|Western Sky Medical Research, El Paso, Texas, 79924, United States|Allergy Asthma and amp Sinus Center S C, Greenfield, Wisconsin, 53228, United States|Novartis Investigative Site, Ranelagh Partido De Berazate, Buenos Aires, 1884, Argentina|Novartis Investigative Site, Buenos Aires, Nueve De Julio, B6500BWQ, Argentina|Novartis Investigative Site, Santa Fe, Rosario, S2000DBS, Argentina|Novartis Investigative Site, Rosario, Santa Fe, S2000JKR, Argentina|Novartis Investigative Site, Calgary, Alberta, T2M 1A6, Canada|Novartis Investigative Site, Montreal, Quebec, H2V 2K1, Canada|Novartis Investigative Site, Angers 09, 49933, France|Novartis Investigative Site, Antony, 92160, France|Novartis Investigative Site, Brest, 29609, France|Novartis Investigative Site, Montpellier cedex 5, 34295, France|Novartis Investigative Site, Paris, 75970, France|Novartis Investigative Site, Reims, 51100, France|Novartis Investigative Site, Saint Mande, 94160, France|Novartis Investigative Site, Toulouse, 31400, France|Novartis Investigative Site, Bramsche, 49565, Germany|Novartis Investigative Site, Erlangen, 91054, Germany|Novartis Investigative Site, Gottingen, 37075, Germany|Novartis Investigative Site, Halle (Saale), 06108, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Marburg, 35039, Germany|Novartis Investigative Site, Daegu, Dalseo Gu, 42602, Korea, Republic of|Novartis Investigative Site, Suwon si, Gyeonggi Do, 16499, Korea, Republic of|Novartis Investigative Site, Seoul, 03080, Korea, Republic of|Novartis Investigative Site, Singapore, 308205, Singapore|Novartis Investigative Site, Komarno, 945 01, Slovakia|Novartis Investigative Site, Levice, 934 01, Slovakia|Novartis Investigative Site, Nove Zamky, 940 34, Slovakia|Novartis Investigative Site, Alicante, Comunidad Valenciana, 03010, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46014, Spain|Novartis Investigative Site, Madrid, 28006, Spain|Novartis Investigative Site, Madrid, 28041, Spain|Novartis Investigative Site, Izmir, 35140, Turkey|Novartis Investigative Site, Kayseri, 38070, Turkey|Novartis Investigative Site, Samsun, 55139, Turkey Less <<
NCT05170724 Chronic Spontaneous Urticaria AVAILABLE - -
NCT04109313 Chronic Spontaneous Urticaria PHASE2 COMPLETED 2022-09-09 Novartis Investigative Site, L... More >>itchfield Park, Arizona, 85340, United States|Novartis Investigative Site, Little Rock, Arkansas, 72205, United States|Novartis Investigative Site, Mission Viejo, California, 92691, United States|Novartis Investigative Site, San Diego, California, 92123, United States|Novartis Investigative Site, Walnut Creek, California, 94598, United States|Novartis Investigative Site, Pembroke Pines, Florida, 33028, United States|Novartis Investigative Site, Owensboro, Kentucky, 42301, United States|Novartis Investigative Site, Ypsilanti, Michigan, 48197, United States|Novartis Investigative Site, Saint Louis, Missouri, 63141, United States|Novartis Investigative Site, Grove City, Ohio, 43123, United States|Novartis Investigative Site, Caba, Buenos Aires, C1414AIF, Argentina|Novartis Investigative Site, La Plata, Buenos Aires, B1902COS, Argentina|Novartis Investigative Site, Ciudad de Mendoza, Mendoza, M5500AWD, Argentina|Novartis Investigative Site, Caba, 1035, Argentina|Novartis Investigative Site, Edegem, Antwerpen, 2650, Belgium|Novartis Investigative Site, Liege, 4000, Belgium|Novartis Investigative Site, Edmonton, Alberta, T5K 1X3, Canada|Novartis Investigative Site, London, Ontario, N6H 5L5, Canada|Novartis Investigative Site, Niagara Falls, Ontario, L2H 1H5, Canada|Novartis Investigative Site, Ottawa, Ontario, K1G 6C6, Canada|Novartis Investigative Site, Verdun, Quebec, H4G 3E7, Canada|Novartis Investigative Site, Quebec, G1V 4W2, Canada|Novartis Investigative Site, Prague 8, Czech Republic, 180 00, Czechia|Novartis Investigative Site, Prague, Prague 1, 11000, Czechia|Novartis Investigative Site, Tabor, 390 01, Czechia|Novartis Investigative Site, Arhus C, DK 8000, Denmark|Novartis Investigative Site, Copenhagen NV, 2400, Denmark|Novartis Investigative Site, Lille Cedex, 59037, France|Novartis Investigative Site, Nantes Cedex 1, 44093, France|Novartis Investigative Site, Nice Cedex, 06202, France|Novartis Investigative Site, Oroshaza, Bekes, 5900, Hungary|Novartis Investigative Site, Budapest, 1085, Hungary|Novartis Investigative Site, Debrecen, 4032, Hungary|Novartis Investigative Site, Pecs, 7632, Hungary|Novartis Investigative Site, Szolnok, 5000, Hungary|Novartis Investigative Site, Ichinomiya, Aichi, 491-0041, Japan|Novartis Investigative Site, Funabashi, Chiba, 273-0031, Japan|Novartis Investigative Site, Hiroshima City, Hiroshima, 734-8551, Japan|Novartis Investigative Site, Obihiro, Hokkaido, 080 0013, Japan|Novartis Investigative Site, Yokohama, Kanagawa, 220-6208, Japan|Novartis Investigative Site, Yokohama, Kanagawa, 221-0825, Japan|Novartis Investigative Site, Yokohama, Kanagawa, 240-0013, Japan|Novartis Investigative Site, Itabashi-ku, Tokyo, 173-8610, Japan|Novartis Investigative Site, Takaoka, Toyama, 933-0871, Japan|Novartis Investigative Site, Gdansk, 80 803, Poland|Novartis Investigative Site, Lodz, 90-265, Poland|Novartis Investigative Site, Lodz, 90-436, Poland|Novartis Investigative Site, Rzeszow, 35 055, Poland|Novartis Investigative Site, Warszawa, 02 777, Poland|Novartis Investigative Site, Moscow, 123182, Russian Federation|Novartis Investigative Site, Saint Petersburg, 194354, Russian Federation|Novartis Investigative Site, St.-Petersburg, 195112, Russian Federation|Novartis Investigative Site, Stavropol, 355000, Russian Federation|Novartis Investigative Site, Kosice, Slovak Republic, 040 15, Slovakia|Novartis Investigative Site, Nove Zamky, 940 34, Slovakia|Novartis Investigative Site, Svidnik, 08901, Slovakia|Novartis Investigative Site, Barcelona, Catalunya, 08003, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08035, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08036, Spain|Novartis Investigative Site, Alicante, Comunidad Valenciana, 03010, Spain|Novartis Investigative Site, Madrid, 28006, Spain|Novartis Investigative Site, Madrid, 28046, Spain|Novartis Investigative Site, Istanbul, TUR, 34098, Turkey|Novartis Investigative Site, Denizli, 20070, Turkey|Novartis Investigative Site, Talas / Kayseri, 38039, Turkey|Novartis Investigative Site, Leeds, LS9 7TF, United Kingdom|Novartis Investigative Site, London, SE1 9RT, United Kingdom|Novartis Investigative Site, Oxford, OX3 7LJ, United Kingdom|Novartis Investigative Site, Plymouth, PL6 8DH, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.97mL

0.39mL

0.20mL

9.85mL

1.97mL

0.99mL

19.70mL

3.94mL

1.97mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories